Evexia Lifecare Ltd. Fundamental Analysis
Evexia Lifecare Ltd. (EVEXIA.BO) shows weak financial fundamentals with a PE ratio of 145.24, profit margin of 1.89%, and ROE of 0.43%. The company generates $1.1B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 35.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze EVEXIA.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakEVEXIA.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateEVEXIA.BO shows balanced valuation metrics.
Growth Score
ModerateEVEXIA.BO shows steady but slowing expansion.
Financial Health Score
ExcellentEVEXIA.BO maintains a strong and stable balance sheet.
Profitability Score
WeakEVEXIA.BO struggles to sustain strong margins.
Key Financial Metrics
Is EVEXIA.BO Expensive or Cheap?
P/E Ratio
EVEXIA.BO trades at 145.24 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, EVEXIA.BO's PEG of -0.11 indicates potential undervaluation.
Price to Book
The market values Evexia Lifecare Ltd. at 0.69 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 94.52 times EBITDA. This signals the market has high growth expectations.
How Well Does EVEXIA.BO Make Money?
Net Profit Margin
For every $100 in sales, Evexia Lifecare Ltd. keeps $1.89 as profit after all expenses.
Operating Margin
Core operations generate 1.71 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.43 in profit for every $100 of shareholder equity.
ROA
Evexia Lifecare Ltd. generates $0.24 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Evexia Lifecare Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Evexia Lifecare Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
EVEXIA.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
145.24
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.11
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.69
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.65
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.007
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.39
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.004
vs 25 benchmark
ROA
Return on assets percentage
0.002
vs 25 benchmark
ROCE
Return on capital employed
0.002
vs 25 benchmark
How EVEXIA.BO Stacks Against Its Sector Peers
| Metric | EVEXIA.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 145.24 | 24.03 | Worse (Expensive) |
| ROE | 0.43% | 1183.00% | Weak |
| Net Margin | 1.89% | -28255.00% (disorted) | Weak |
| Debt/Equity | 0.01 | -1.66 (disorted) | Distorted |
| Current Ratio | 1.39 | 3.26 | Neutral |
| ROA | 0.24% | 396.00% | Weak |
EVEXIA.BO outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Evexia Lifecare Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Value, Commodity
EPS CAGR
N/A
Industry Style: Cyclical, Value, Commodity
FCF CAGR
N/A
Industry Style: Cyclical, Value, Commodity